Literature DB >> 22075319

Removal of retrievable vena cava filters in routine practice: a multicenter study.

Tatiana Michaelov1, Dorit Blickstein, Daria Levy, Shlomo Berliner, Martin H Ellis.   

Abstract

UNLABELLED: Vena cava filters (VCFs) are used to prevent pulmonary embolism when anticoagulation is contraindicated or in the event of progression of thrombosis despite adequate anticoagulation. Retrievable VCFs provide a potential advantage over permanent VCFs, but the appropriateness of their use and the frequency with which they are removed is not well established.
OBJECTIVES: Document the indications for insertion of retrievable VCFs, filter removal in hospital practice.
METHODS: Observational study conducted in three academic medical centers. Consecutive patients undergoing retrievable VCF insertion were identified. Clinical data was extracted from the patients' charts and follow up data were obtained from treating physicians after discharge.
RESULTS: 300 patients were studied. The indication for filter insertion was acute bleeding (46.1%) or surgery (24.2%) in patients with acute thrombosis, prevention of venous thromboembolism in trauma (13.3%), potential bleeding in patients with deep vein thrombosis (9.1%) thromboembolism while on adequate anticoagulation (5.7%) and other (1.3%). 21 (7%) filters were removed. An unsuccessful attempt at retrieval was undertaken in a further 9 (3%) patients.
CONCLUSIONS: The use of retrievable VCFs was appropriate, with the possible exception of their prophylactic use in major trauma. The majority of VCFs were not removed, for reasons that are not apparent.
Copyright © 2011 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22075319     DOI: 10.1016/j.ejim.2011.08.023

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  1 in total

1.  Improvement of hemodynamic performance using novel helical flow vena cava filter design.

Authors:  Ying Chen; Peng Zhang; Xiaoyan Deng; Yubo Fan; Yubin Xing; Ning Xing
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.